Related Experiment Video

Updated: May 8, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

PARP-1 regulates expression of TGF-β receptors in T cells

Pin Zhang1, Hiroko Nakatsukasa, Eric Tu

  • 1Mucosal Immunology Section, Oral Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD;

Blood
|August 14, 2013
PubMed

Insights

Poly(ADP-ribose) polymerase-1 (PARP-1) regulates transforming growth factor-β (TGF-β) receptors (TβRs) in CD4(+) T cells. Inhibiting PARP-1 increases TβR expression and enhances TGF-β signaling, offering new therapeutic targets.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor-β (TGF-β) receptors (TβRs) are critical for TGF-β signal transduction in T cells.
  • Mechanisms regulating TβR expression and function in T cells are not fully understood.

Purpose of the Study:

  • To investigate the role of Poly(ADP-ribose) polymerase-1 (PARP-1) in regulating TβR expression and TGF-β signaling in CD4(+) T cells.
  • To elucidate the molecular mechanisms by which PARP-1 affects TβRI and TβRII expression.

Main Methods:

  • Investigated PARP-1 regulation of TβRI and TβRII expression in CD4(+) T cells.
  • Utilized molecular biology techniques to assess receptor expression and signaling pathways.
  • Examined PARP-1 binding to TβRII promoter and the role of PARP-1 enzymatic activity on TβRI expression.

Main Results:

  • PARP-1 was found to regulate TβRI and TβRII expression in CD4(+) T cells.
  • Inhibition of PARP-1 led to increased TβRI and TβRII expression through distinct mechanisms.
  • PARP-1 selectively bound to the TβRII promoter, while its enzymatic activity inhibited TβRI expression.
  • PARP-1 inhibition enhanced TβR expression in human CD4(+) T cells.

Conclusions:

  • PARP-1 plays a significant role in modulating TβR expression and TGF-β signaling in T cells.
  • Targeting PARP-1 could be a strategy to modulate TGF-β signaling in T cell-mediated processes.
  • Findings provide novel insights into the regulation of TGF-β signaling pathways in T cells.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...